Connect with us
Information
About Us
Contact Us
Careers
Partnerships
Advertise With Us
Authors
Browse Topics
Events
Disclaimer
Privacy Policy
Australia
North America
World
Login
Investing News
Network
Your trusted source for investing success
North America
Australia
World
My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
Reports & Guides
Market Outlook Reports
Investing Guides
Resource
Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals
Tech
Life Science
nasdaq:tyme
POPULAR ARTICLES
TYME Launches TYME-88-PANC Trial
5 Top Weekly NASDAQ Biotech & Pharma Stocks: Corvus Soars
TYME Provides Updated Data on TYME-88-Panc Phase II Study
LATEST ARTICLES
TYME Secures Capital to Advance Pivotal Studies of SM-88 in Metastatic Pancreatic Cancer
TYME Receives FDA Guidance on Pivotal Trial for SM-88 in Treatment for Advanced Pancreatic Cancer
TYME’s Novel Metabolic-Based Cancer Therapy, SM-88, Improves Survival in Phase II Study
Tyme Exceeds Enrollment Expectations for the Phase II Trial of SM-88 in Pancreatic Cancer
Tyme Technologies Provides Clinical and Corporate Update for Fiscal 1Q 2019
Latest News
Spearmint Significantly Increases Acreage on the Sisson North Tungsten Project in New Brunswick
Suspension from Quotation
Tartana executes HOA to process Copper Ore in Mungana Plant
Reinstatement to Quotation
$2.85m Placement in Conjunction with 815Koz AuEq Acquisition
More News
